Thymosin Alpha 1 (Tα1) is a peptide that plays a key role in the immune system by enhancing the function of T-cells, which are crucial for immune responses. It is a naturally occurring peptide produced by the thymus gland and is involved in regulating immune cell development, differentiation, and activation.
Tα1 is studied for its potential immunomodulatory effects, including boosting the body’s defense against infections, enhancing immune function in immunocompromised patients (e.g., those with chronic viral infections or cancer), and improving the body’s response to vaccines. It has been investigated as a potential treatment for conditions like hepatitis B, HIV, cancer, and chronic infections.
Due to its immune-enhancing properties, Thymosin Alpha 1 is sometimes used as an adjunct in therapy for boosting immunity, although it is still primarily used in research and clinical trials.
